跳至主要内容
临床试验/ITMCTR2000003002
ITMCTR2000003002招募中1 期

A multicenter, randomized, controlled trial for integrated chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19) based on the 'Truncated Torsion' strategy

Huangshi Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 80(—)
性别
All

入选标准

  • 1. Hospitalized patients with novel coronavirus pneumonia confirmed by pathogenic detection
  • 2. Meet any one of the criteria for severe type:
  • 1) Respiratory distress: RP >= 30/min;
  • 2) At rest, the oxygen saturation <= 93%;
  • 3) Arterial partial pressure of oxygen (PaO2)/Fraction of inspiration (FiO2)(Oxygenation Index, P/F) <= 300mmHg.
  • 3. Aged 18 to 75 years;
  • 4. Signed informed consent.

排除标准

  • 1. Pregancy or lactating women;
  • 2. People with allergies or allergies to components of Truncated Torsion formula;
  • 3. Patients with serious basic diseases such as malignant tumor, cirrhosis, chronic renal failure (uremic stage), hematological disease, HIV, etc.;
  • 4. Patients with obstructive pneumonia caused by lung tumor, pulmonary fibrosis, alveolar proteinosis and allergic alveolitis;
  • 5. Patients with long-term use of hormone, immunosuppressant and other drugs;
  • 6. Severe mental illness or inability to cooperate with investigators.

研究者

发起方
Huangshi Hospital of Traditional Chinese Medicine

相似试验